Novo's Clayton facility makes semaglutide, the active ingredient in Wegovy and diabetes drug Ozempic. It also does ...

A federal appeals court on Monday rejected Novo Nordisk's challenge to the U.S. government’s program that gives its Medicare ...

Novo Nordisk is well-positioned in the obesity drug market, with strong financials and anticipation for its oral Wegovy pill.

Novo Nordisk is one of Europe’s largest companies and a global leader in the treatment of two major lifestyle diseases – ...

Novo Nordisk (NYSE:NVO) shares have moved little in recent sessions, with investors taking a wait-and-see approach. Market participants are weighing the company's recent performance metrics against ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Yesterday, the U.S. Court of Appeals for the Third Circuit nixed the latest challenge filed by a major pharmaceutical company ...

The Danish drugmaker plans to cut 9,000 jobs or 11% of its workforce, which would save it 8 billion Danish krone ($1.25 ...

Vltava Fund, an investment management company, recently released its third-quarter 2025 investor letter. A copy of the letter ...

With Cork a crucial part of its global supply chain, Eli Lilly's weight loss drugs are shaking up an industry once ruled by ...